Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spin-Out A Neat Solution For Sanofi’s Manufacturing Millstone

Bypasses Union Objections To Downsizing

Executive Summary

Hudson finds solution for legacy sites which have dogged predecessors.

You may also be interested in...



Sanofi API Unit Expects $1bn Sales By 2022

Sanofi has announced plans to create the world’s second-largest API manufacturer to help ease European drugmakers’ dependence on supplies of raw materials from China and India.

Sanofi Highlights MS Asset After Solid Q4

The French drugmaker ended 2019 with a solid Q4 performance and news that its BTK inhibitor SAR442168 will start Phase III testing in progressive and elapsing multiple sclerosis. 

Sofinnova Raises €472m To Build Europe’s Biggest Early-Stage Investment Fund

The VC firm is making the most of a surge of capital from new and established investors who believe in the promise of European biopharma start-ups.

Topics

Related Companies

UsernamePublicRestriction

Register

SC141720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel